Web27 Oct 2024 · SPRINT was an open-label, randomized controlled trial comparing systolic blood pressure targets of less than 140 mm H versus less than 120 mm Hg in patients over 50 with systolic blood pressure over 130 mm Hg. The study terminated early due to the benefit observed on primary cardiovascular outcomes in the intensive treatment group. Web6 Dec 2024 · This is also supported by two meta-analyses. 8,9 However, it does not solve the puzzle of what the optimal BP goal is, because the method used for office BP measurement in the SPRINT study (automated measurement without personnel present) had not previously been used in any clinical trial. The ability to generalise the SPRINT results to …
ACC/AHA Hypertension Guideline: What Is New? What Do We Do?
Web11 Sep 2015 · The SPRINT study evaluates the benefits of maintaining a new target for systolic blood pressure, the top number in a blood pressure reading, among a group of patients 50 years and older at increased risk for heart disease or who have kidney disease. Web1 day ago · Blood pressure (BP) is one of the most important determinants of the cardiovascular and renal health of populations. This is why lowering the prevalence of hypertension, defined as a systolic BP >140 mm Hg or a diastolic BP >90 mm Hg, has been set as a major objective by the World Health Organization. 1 A pooled analysis of >1400 … reflow combat ankle boot - lug sole
SPRINT Trial Results Hypertension
Web4 Nov 2015 · Systolic Blood Pressure Intervention Trial. 2. Systolic Blood Pressure Intervention Trial • SPRINT is an unmasked open-label randomized controlled clinical trial examining the effect of a high blood pressure treatment strategy aimed at reducing systolic blood pressure (SBP) to a lower goal than is currently recommended. • It was sponsored ... Web25 May 2024 · Aiming for an SBP goal of 120 mm Hg in high-risk patients prevents some adverse CV events at the expense of a small number of drug-related adverse events. If the … Web29 Jun 2024 · Most patients require two agents to control their BP (Chobanian, 2008) and side effects are less likely when using low doses (Salaam et al, 2024). Further, a lower BP target is probably better (SPRINT 2015; Zhang, 2024). Thus, a low dose combination of two meds at 25% or 50% max dose of each agent is a good option, especially if BP is more … reflow checker